Should travelers be screened for multi-drug resistant (MDR) bacteria after visiting high risk areas such as India?
A study of risk factors for being infected with tigecycline resistant K. pneumonia in a hospital setting found that the only independent risk factor was prior use of kinolones [17]. [...]it seems that, in particular, South East Asia is a hotspot for developing and spreading MDR bacteria [18,19], and particularly hospitals are identified a source [20,21], as has also been reported from Greece [22]. Medical tourism and hospital as hot-spots for MDR bacteria "Medical tourism" is the term used for patients traveling for treatment at a medical facility in another country. Because hospitals are hotspots for MDR bacteria, medical tourisms is of particular concern in the spread of MDR bacteria between countries [26,27]..
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2016 |
---|---|
Erschienen: |
2016 |
Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
---|---|
Enthalten in: |
Travel medicine and infectious disease - 14(2016), 6, Seite 591-594 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Petersen, Eskild [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antibiotics |
---|
doi: |
10.1016/j.tmaid.2016.11.014 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC1989884091 |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | OLC1989884091 | ||
003 | DE-627 | ||
005 | 20230511220015.0 | ||
007 | tu | ||
008 | 170207s2016 xx ||||| 00| ||eng c | ||
024 | 7 | |a 10.1016/j.tmaid.2016.11.014 |2 doi | |
028 | 5 | 2 | |a PQ20170301 |
035 | |a (DE-627)OLC1989884091 | ||
035 | |a (DE-599)GBVOLC1989884091 | ||
035 | |a (PRQ)c1081-978eea2f2aaa62425cef3051593aaa346b4c8abbbcbfdf7c31e03f463b47c65f0 | ||
035 | |a (KEY)0527842220160000014000600591shouldtravelersbescreenedformultidrugresistantmdrb | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q DNB |
100 | 1 | |a Petersen, Eskild |e verfasserin |4 aut | |
245 | 1 | 0 | |a Should travelers be screened for multi-drug resistant (MDR) bacteria after visiting high risk areas such as India? |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
520 | |a A study of risk factors for being infected with tigecycline resistant K. pneumonia in a hospital setting found that the only independent risk factor was prior use of kinolones [17]. [...]it seems that, in particular, South East Asia is a hotspot for developing and spreading MDR bacteria [18,19], and particularly hospitals are identified a source [20,21], as has also been reported from Greece [22]. Medical tourism and hospital as hot-spots for MDR bacteria "Medical tourism" is the term used for patients traveling for treatment at a medical facility in another country. Because hospitals are hotspots for MDR bacteria, medical tourisms is of particular concern in the spread of MDR bacteria between countries [26,27]. | ||
650 | 4 | |a Travel | |
650 | 4 | |a Bacteria | |
650 | 4 | |a Diarrhea | |
650 | 4 | |a Disease control | |
650 | 4 | |a Chronic illnesses | |
650 | 4 | |a Antibiotics | |
650 | 4 | |a Plasmids | |
650 | 4 | |a Multidrug resistant organisms | |
650 | 4 | |a Hospitalization | |
650 | 4 | |a Risk factors | |
650 | 4 | |a Nosocomial infections | |
650 | 4 | |a Medical tourism | |
650 | 4 | |a Pneumonia | |
650 | 4 | |a Genomics | |
650 | 4 | |a Hospitals | |
700 | 1 | |a Mohsin, Jalila |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Travel medicine and infectious disease |d Amsterdam [u.a.] : Elsevier, 2003 |g 14(2016), 6, Seite 591-594 |w (DE-627)474928004 |w (DE-600)2170891-5 |x 1477-8939 |7 nnns |
773 | 1 | 8 | |g volume:14 |g year:2016 |g number:6 |g pages:591-594 |
856 | 4 | 1 | |u http://dx.doi.org/10.1016/j.tmaid.2016.11.014 |3 Volltext |
856 | 4 | 2 | |u http://search.proquest.com/docview/1848802478 |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a GBV_ILN_4219 | ||
951 | |a AR | ||
952 | |d 14 |j 2016 |e 6 |h 591-594 |